http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SU-1222197-A3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69c91bbf0395db010b4806f50d808c4e |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4995 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D451-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-08 |
| filingDate | 1982-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1986-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a317a1c86c4643c7683e304d16a40eb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a94835887205b56f947e4fd066d176f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a045682a2b264f65f34edc1ca6ebbad7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47ce47223b27bfb76b237dc27cb6e14c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3666281d9ad47ec315ae898eb958fdd9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ddc1e70b2ec9e46c5782d7625ec5566c |
| publicationDate | 1986-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | SU-1222197-A3 |
| titleOfInvention | Method of producing bicyclic compounds or stereoisomers of the compounds or their pharmaceutically acceptable salts with acids |
| abstract | New bicyclic compounds of the general formula (I), <IMAGE> (I) wherein R1 and R2 each represent a C1-6 alkyl group, and R3 is an etherified hydroxy group of the formula -CR4, wherein R4 is benzyl group, benzhydryl group or a phenyl group bearing optionally a phenyl or a trihalomethyl substituent or one or more halogen substituent(s), or R3 is an esterified hydroxy group of the formula -OCO-R5, which represents a phenyl-(C1-5 alkyl)-carbonyloxy group, a cinnamoyloxy group having optionally a halogen or one or more C1-4 alkoxy substituent(s), a benzoyloxy group having optionally a C1-4 alkyl, phenyl or trihalomethyl substituent or one or more C1-4 alkoxy substituent(s), one or more halo substituent(s) and/or nitro substituent, a benzyloyloxy group, a xanthene-9-carbonyloxy group, an optionally substituted naphthoyloxy group, or an acyloxy group derived from a five- or six-membered heterocyclic carboxylic acid bearing optionally a halo substituent on the ring, are prepared by etherifying or esterifying a bicyclic compound of the general formula (II), <IMAGE> (II) wherein R1 and R2 are as defined above. The new compounds according to the invention possess anti-arrhythmic effects and can be applied to advantage in the therapy of cardiac rhythm disorders. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2503663-C2 |
| priorityDate | 1981-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 68.